Literature DB >> 15378764

Allergen-induced proteolytic cleavage of annexin-1 and activation of cytosolic phospholipase A2 in the lungs of a mouse model of asthma.

Youn Wook Chung1, Hae Yeun Oh, Ji Yeong Kim, Jae-Hong Kim, Ick Young Kim.   

Abstract

To identify proteins that might play an important role in allergen-induced asthma, we analyzed lung extracts prepared from allergen (ovalbumin)-challenged animals in a mouse model of this condition. The combination of two-dimensional gel electrophoresis and mass spectrometry revealed that annexin-1, a 37 kDa anti-inflammatory protein that inhibits the activity of cytosolic phospholipase A(2) (cPLA(2)), was down-regulated by allergen challenge in the lungs of ovalbumin-sensitized mice. Immunoblot analysis showed that this effect of ovalbumin challenge was attributable to proteolytic cleavage of annexin-1. The ovalbumin-induced degradation of annexin-1 was blocked by pretreatment of mice with the antioxidant N-acetylcysteine (NAC) or with sodium selenite, both of which have previously been shown to exert anti-inflammatory effects in this asthma model. Ovalbumin challenge also both increased the expression of cPLA(2) in lung tissue and reduced the extent of the interaction between cPLA(2) and annexin-1, and these effects were inhibited by NAC or selenite. Moreover, the concentrations of cysteinyl leukotrienes in bronchoalveolar lavage fluid and of leukotriene B(4) in lung tissue were increased by ovalbumin challenge in a NAC- or selenite-sensitive manner. Together, these results suggest that allergen-induced oxidative stress results in proteolysis of annexin-1 and consequent up-regulation of cPLA(2) activity and leukotriene production in this mouse model of asthma, and that the anti-inflammatory effects of selenite may provide a basis for the development of new antiasthmatic drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378764     DOI: 10.1002/pmic.200400895

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  13 in total

1.  85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study.

Authors:  M Sokolowska; M Borowiec; A Ptasinska; M Cieslak; J H Shelhamer; M L Kowalski; R Pawliczak
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

2.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

3.  Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population.

Authors:  Hoang Kim Tu Trinh; Duy Le Pham; Su-Chin Kim; Ri-Yeon Kim; Hae-Sim Park; Seung-Hyun Kim
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

4.  FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication.

Authors:  XuSheng Ma; KeShan Zhang; ZhiKuan Luo; XiaoFeng Nian; S K Mohiuddin Choudhury; ZiXiang Zhu; Rui Song; JingJing Pei; YanLi Huo; YuanYuan Li; Fan Yang; WeiJun Cao; HuiSheng Liu; XiangTao Liu; HaiXue Zheng
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

5.  A selective antagonist of histamine H₄ receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1.

Authors:  T Somma; L Cinci; G Formicola; A Pini; R Thurmond; M Ennis; D Bani; E Masini
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.

Authors:  Vincenzo Cerundolo; Graham Ogg; Rachael Jarrett; Mariolina Salio; Antonia Lloyd-Lavery; Sumithra Subramaniam; Elvire Bourgeois; Charles Archer; Ka Lun Cheung; Clare Hardman; David Chandler; Maryam Salimi; Danuta Gutowska-Owsiak; Jorge Bernardino de la Serna; Padraic G Fallon; Helen Jolin; Andrew Mckenzie; Andrzej Dziembowski; Ewa Izabela Podobas; Wojciech Bal; David Johnson; D Branch Moody
Journal:  Sci Transl Med       Date:  2016-02-10       Impact factor: 17.956

7.  Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects.

Authors:  Mark Yoder; Yan Zhuge; Yang Yuan; Oksana Holian; Sherry Kuo; Richard van Breemen; Larry L Thomas; Hazel Lum
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-05       Impact factor: 5.764

8.  CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.

Authors:  Clare S Hardman; Yi-Ling Chen; Maryam Salimi; Rachael Jarrett; David Johnson; Valtteri J Järvinen; Raymond J Owens; Emmanouela Repapi; David J Cousins; Jillian L Barlow; Andrew N J McKenzie; Graham Ogg
Journal:  Sci Immunol       Date:  2017-12-22

9.  Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1.

Authors:  Samia Yazid; Ajantha Sinniah; Egle Solito; Virginia Calder; Rod J Flower
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

10.  Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis.

Authors:  S Arora; W Lim; P Bist; R Perumalsamy; H M Lukman; F Li; L B Welker; B Yan; G Sethi; P A Tambyah; A-M Fairhurst; S Alonso; L H K Lim
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.